Clinical trial
Intrathecal Gemcitabine to Treat Neoplastic Meningitis, IT Gemcitabine
NCT00074607 · Baylor College of Medicine, Other · Terminated
Key facts
| NCT number | NCT00074607 |
|---|---|
| Title | Intrathecal Gemcitabine to Treat Neoplastic Meningitis, IT Gemcitabine |
| Official title | Intrathecal Gemcitabine Therapy for Neoplastic Meningitis: A Phase I and Pharmacokinetic Study |
| Lead sponsor | Baylor College of Medicine, Other |
| Collaborators | University of Pittsburgh National Cancer Institute (NCI) NIH Children's Hospital of Pittsburg Seattle Children's Hospital Mayo Clinic Brown University |
| Status | Terminated |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Meningitis, Neoplasms |
| Intervention type | Drug |
| Interventions | Gemcitabine |
| Enrollment | 10 |
| Start date | Dec 1, 2001 |
| Primary completion | Jul 1, 2005 |
| Completion | Apr 1, 2007 |
| First posted | Dec 18, 2003 |
| Last update posted | Nov 12, 2012 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: